For example, some state Medicaid applications in recent years have enacted prescription medication restrictions by placing caps or limits on the number of prescriptions a patient can fill each month. The results of this systematic review of past studies shows that restricting the option of prescription medications or prohibiting gain access to could have collateral unwanted effects on sufferers' health and might not produce the anticipated cost-savings.The URMC study evaluated 537 patients for more than 10 years once they were treated for leukemia between 1996 and 2001. All received multi-agent chemotherapy that included doxorubicin, regarded as toxic to the center. Patients had been randomized to two groups, with or with out a dose of intravenous Zinecard instantly prior to receiving the chemotherapy. Later, experts assessed each patient for heart harm at three different points after chemotherapy. Using standard measures, they looked at heart muscles function and structure. Related StoriesMD Anderson study reveals why chemotherapy medicines not effective for many pancreatic cancer patientsCrucial switch in single DNA foundation predisposes children to aggressive form of cancerNew RNA test of blood platelets can be used to detect location of cancerFor both sets of sufferers, the five-year survival without evidence of leukemia was the same.